Cinara Vasconcelos da Silva, Paula Maiana Oliveira Ferreira, Matheus Da Silva Ferreira, Amanda Dos Santos Teles Cardoso, Valdinéa dos Santos Dias, Cleber Alberto Schmidt, Aníbal De Freitas Santos Júnior, Edith Cristina Laignier Cazedey
{"title":"Quality evaluation and dissolution profile of hydrochlorothiazide tablets available in Salvador-BA, Brazil","authors":"Cinara Vasconcelos da Silva, Paula Maiana Oliveira Ferreira, Matheus Da Silva Ferreira, Amanda Dos Santos Teles Cardoso, Valdinéa dos Santos Dias, Cleber Alberto Schmidt, Aníbal De Freitas Santos Júnior, Edith Cristina Laignier Cazedey","doi":"10.15446/rcciquifa.v52n1.103374","DOIUrl":null,"url":null,"abstract":"Introduction: hydrochlorothiazide is a diuretic drug indicated for the continuoustreatment of hypertension. The drug is presented as a medicine in the form of tabletscontaining only one active agent or combined in formulations with concentrationsof 12.5, 25 and 50 mg. The 25 mg dosage is the most widely used in medical therapy.Therefore, considering the incidence of hypertension and prolonged use of the drug, it isnecessary to determine the quality of hydrochlorothiazide tablets available on public andprivate pharmacies of Salvador, Bahia. Complaints regarding the compromised qualityof the products stored in drugstores are reported very often. Material and Methods:following the drug monograph, and consequently the pharmacopoeial methods, thisstudy aimed to carry out quality control, physicochemical and microbiological testingof medicines containing hydrochlorothiazide, including the trade name (reference – R),generic (G) and similar (S) medicine, which is provided by National Health Service(aka SUS – Sistema Único de Saúde). Results: it was observed that the samples of themedicines: R, G and S samples showed complies with the pharmacopoeial tests, exceptfor the assay of generic which content presented out of specification.","PeriodicalId":21220,"journal":{"name":"Revista Colombiana de Ciencias Químico-Farmacéuticas","volume":"45 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Colombiana de Ciencias Químico-Farmacéuticas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15446/rcciquifa.v52n1.103374","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: hydrochlorothiazide is a diuretic drug indicated for the continuoustreatment of hypertension. The drug is presented as a medicine in the form of tabletscontaining only one active agent or combined in formulations with concentrationsof 12.5, 25 and 50 mg. The 25 mg dosage is the most widely used in medical therapy.Therefore, considering the incidence of hypertension and prolonged use of the drug, it isnecessary to determine the quality of hydrochlorothiazide tablets available on public andprivate pharmacies of Salvador, Bahia. Complaints regarding the compromised qualityof the products stored in drugstores are reported very often. Material and Methods:following the drug monograph, and consequently the pharmacopoeial methods, thisstudy aimed to carry out quality control, physicochemical and microbiological testingof medicines containing hydrochlorothiazide, including the trade name (reference – R),generic (G) and similar (S) medicine, which is provided by National Health Service(aka SUS – Sistema Único de Saúde). Results: it was observed that the samples of themedicines: R, G and S samples showed complies with the pharmacopoeial tests, exceptfor the assay of generic which content presented out of specification.
导读:氢氯噻嗪是一种利尿药,适用于高血压的持续治疗。氢氯噻嗪是一种利尿药,用于高血压的持续治疗。该药以片剂形式出现,片剂中只含有一种活性药物,也有浓度为 12.5、25 和 50 毫克的复方制剂。因此,考虑到高血压的发病率和长期用药的情况,有必要对巴伊亚州萨尔瓦多市公立和私立药店出售的氢氯噻嗪片剂的质量进行检测。关于药店所售药品质量有问题的投诉屡见报端。材料与方法:本研究旨在按照药物专著和药典方法,对含有氢氯噻嗪的药品进行质量控制、理化和微生物学检测,其中包括由国家卫生服务系统(又称 SUS - Sistema Único de Saúde)提供的商品名(参考 - R)、非专利药(G)和类似药(S)。结果:观察发现,R、G 和 S 三种药品的样本均显示出相似性:R、G 和 S 样品均符合药典检测标准,只有非专利药的检测结果不符合标准。